FENNEC PHARMACEUTICALS INC

Historical 13F Holders

Symbol
FENC
CUSIP
31447P100
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 31447P100 since 12/18/2024, largest first.

Filer % of Class Filed
Rosalind Advisors, Inc. 13G/A
9.6% 8/13/2026
Event 6/30/2026
Orin Hirschman 13G/A
7.1% 10/19/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Sonic Fund II, L.P. 13G/A
4.5% 11/16/2026
Event 9/30/2026
Solas Capital Management, LLC 13G/A
4.1% 11/16/2026
Event 9/30/2026
DG Capital Management, LLC 13G/A
4.1% 2/14/2025
Event 12/31/2024
Southpoint Capital Advisors LP 13G/A
0% 8/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 120 18.0 M $191M
2026 Q2 106 16.3 M $175M
2026 Q1 92 16.2 M $99.6M
2025 Q4 96 15.5 M $120M
2025 Q3 84 13.9 M $130M
2025 Q2 79 13.6 M $113M
2025 Q1 69 13.4 M $81.6M
2024 Q4 65 16.0 M $101M
2024 Q3 64 14.9 M $74.6M
2024 Q2 65 14.4 M $87.7M
2024 Q1 66 14.5 M $161M
2023 Q4 58 15.0 M $168M
2023 Q3 57 14.3 M $108M
2023 Q2 57 14.1 M $125M
2023 Q1 55 13.0 M $108M
2022 Q4 44 12.5 M $120M
2022 Q3 36 11.4 M $92.1M
2022 Q2 30 11.3 M $63.2M
2022 Q1 30 11.4 M $64.1M
2021 Q4 31 11.3 M $49.9M
2021 Q3 34 11.6 M $110M
2021 Q2 41 12.1 M $88.0M
2021 Q1 54 14.4 M $89.3M
2020 Q4 54 14.5 M $108M
2020 Q3 57 13.8 M $83.8M
2020 Q2 57 13.9 M $116M
2020 Q1 31 9.46 M $56.2M
2019 Q4 32 10.1 M $65.7M
2019 Q3 28 8.47 M $40.7M
2019 Q2 32 8.99 M $36.0M
2019 Q1 50 9.64 M $46.7M
2018 Q4 48 9.74 M $62.2M
2018 Q3 49 9.46 M $77.6M
2018 Q2 45 9.42 M $98.4M
2018 Q1 22 7.62 M $92.2M
2017 Q4 18 7.16 M $72.3M
2017 Q3 13 5.21 M $57.7M